MYOMO INC(NYSEARCA:MYO) stock Fundamental Analysis

Fundamental Rating

Overall MYO gets a fundamental rating of 4 out of 10. We evaluated MYO against 189 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for MYO as it has an excellent financial health rating, but there are worries on the profitability. MYO shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

MYO had negative earnings in the past year.

In the past year MYO has reported a negative cash flow from operations.

MYO had negative earnings in each of the past 5 years.

In the past 5 years MYO always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of MYO (-14.64%) is comparable to the rest of the industry.

MYO has a Return On Equity (-25.02%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-14.64%
ROE	-25.02%
ROIC	N/A

ROA(3y)-58.67%

ROA(5y)-62.8%

ROE(3y)-94.75%

ROE(5y)-92.3%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MYO has a Gross Margin of 71.23%. This is amongst the best in the industry. MYO outperforms 80.95% of its industry peers.

MYO's Gross Margin has improved in the last couple of years.

MYO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	71.23%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.45%

GM growth 5Y2.49%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.

MYO has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, MYO has more shares outstanding

MYO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 3.04 indicates that MYO is not in any danger for bankruptcy at the moment.

MYO has a Altman-Z score of 3.04. This is in the better half of the industry: MYO outperforms 72.49% of its industry peers.

There is no outstanding debt for MYO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	3.04

ROIC/WACCN/A

WACC8.83%

2.3 Liquidity

MYO has a Current Ratio of 3.22. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.

MYO has a Current ratio of 3.22. This is comparable to the rest of the industry: MYO outperforms 56.08% of its industry peers.

MYO has a Quick Ratio of 2.91. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.

MYO has a better Quick ratio (2.91) than 62.96% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.22
Quick Ratio	2.91

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.29% over the past year.

Looking at the last year, MYO shows a very strong growth in Revenue. The Revenue has grown by 69.18%.

MYO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.36% yearly.

EPS 1Y (TTM)39.29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%85.71%

Revenue 1Y (TTM)69.18%

Revenue growth 3Y32.93%

Revenue growth 5Y53.36%

Sales Q2Q%153.74%

3.2 Future

Based on estimates for the next years, MYO will show a very strong growth in Earnings Per Share. The EPS will grow by 40.96% on average per year.

MYO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.48% yearly.

EPS Next Y31.08%

EPS Next 2Y47.08%

EPS Next 3Y47.18%

EPS Next 5Y40.96%

Revenue Next Year67.5%

Revenue Next 2Y42.81%

Revenue Next 3Y37.49%

Revenue Next 5Y28.48%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYO. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYO. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as MYO's earnings are expected to grow with 47.18% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y47.08%

EPS Next 3Y47.18%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MYO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MYOMO INC

NYSEARCA:MYO (4/30/2025, 8:23:38 PM)

After market: 4.63 -0.07 (-1.49%)

4.7

+0.07 (+1.51%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)03-10 2025-03-10/amc

Earnings (Next)05-07 2025-05-07/amc

Inst Owners54.37%

Inst Owner Change0.22%

Ins Owners5.86%

Ins Owner Change-2.98%

Market Cap161.59M

Analysts80

Price Target9.44 (100.85%)

Short Float %2.48%

Short Ratio1.76

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)39.61%

Min EPS beat(2)28.72%

Max EPS beat(2)50.5%

EPS beat(4)3

Avg EPS beat(4)33.14%

Min EPS beat(4)-4.22%

Max EPS beat(4)57.57%

EPS beat(8)5

Avg EPS beat(8)17.94%

EPS beat(12)9

Avg EPS beat(12)17.61%

EPS beat(16)12

Avg EPS beat(16)16.64%

Revenue beat(2)2

Avg Revenue beat(2)16.57%

Min Revenue beat(2)12.41%

Max Revenue beat(2)20.73%

Revenue beat(4)3

Avg Revenue beat(4)6.69%

Min Revenue beat(4)-8.67%

Max Revenue beat(4)20.73%

Revenue beat(8)6

Avg Revenue beat(8)6.55%

Revenue beat(12)8

Avg Revenue beat(12)7.61%

Revenue beat(16)12

Avg Revenue beat(16)15.01%

PT rev (1m)0%

PT rev (3m)20.65%

EPS NQ rev (1m)-12.59%

EPS NQ rev (3m)-26.67%

EPS NY rev (1m)0%

EPS NY rev (3m)-231.43%

Revenue NQ rev (1m)4.53%

Revenue NQ rev (3m)17.26%

Revenue NY rev (1m)19.13%

Revenue NY rev (3m)19.13%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	4.96
P/FCF	N/A
P/OCF	N/A
P/B	6.54
P/tB	6.54
EV/EBITDA	N/A

EPS(TTM)-0.17

EYN/A

EPS(NY)-0.12

Fwd EYN/A

FCF(TTM)-0.14

FCFYN/A

OCF(TTM)-0.1

OCFYN/A

SpS0.95

BVpS0.72

TBVpS0.72

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.64%
ROE	-25.02%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	71.23%
FCFM	N/A

ROA(3y)-58.67%

ROA(5y)-62.8%

ROE(3y)-94.75%

ROE(5y)-92.3%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.45%

GM growth 5Y2.49%

F-Score5

Asset Turnover0.77

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	660.56%
Cap/Sales	4.18%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.22
Quick Ratio	2.91
Altman-Z	3.04

F-Score5

WACC8.83%

ROIC/WACCN/A

Cap/Depr(3y)269.1%

Cap/Depr(5y)214.88%

Cap/Sales(3y)1.88%

Cap/Sales(5y)1.72%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)39.29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%85.71%

EPS Next Y31.08%

EPS Next 2Y47.08%

EPS Next 3Y47.18%

EPS Next 5Y40.96%

Revenue 1Y (TTM)69.18%

Revenue growth 3Y32.93%

Revenue growth 5Y53.36%

Sales Q2Q%153.74%

Revenue Next Year67.5%

Revenue Next 2Y42.81%

Revenue Next 3Y37.49%

Revenue Next 5Y28.48%

EBIT growth 1Y24.6%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year82.25%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y26.41%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y46.7%

OCF growth 3YN/A

OCF growth 5YN/A

MYOMO INC (MYO) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens